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The receptor for advanced glycation end products (RAGE) is a transmembrane receptor of 
the immunoglobulin superfamily, capable of binding a broad repertoire of ligands. RAGE-
ligands interaction induces a series of signal transduction cascades and lead to the activation 
of transcription factor NF- B as well as increased expression of cytokines, chemokines, and 
adhesion molecules. These effects endow RAGE with the role in the signal transduction from 
pathogen substrates to cell activation during the onset and perpetuation of inflammation. 
RAGE signaling and downstream pathways have been implicated in a wide spectrum of 
inflammatory-related pathologic conditions such as arteriosclerosis, Alzheimer's disease, 
arthritis, acute respiratory failure, and sepsis. Despite the significant progress in other RAGE 
studies, the functional importance of the receptor in clinical situations and inflammatory 
diseases still remains to be fully realized. In this review, we will summarize current 
understandings and lines of evidence on the molecular mechanisms through which RAGE 
signaling contributes to the pathogenesis of the aforementioned inflammation-associated 
conditions. 
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